Scarica l'app Stockscreener
6.63
0.60%
-0.04
Pre-mercato:
6.83
0.20
+3.02%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AVTX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.67
Aprire:
$6.6
Volume 24 ore:
22,422
Relative Volume:
0.24
Capitalizzazione di mercato:
$71.79M
Reddito:
$1.93M
Utile/perdita netta:
$-7.96M
Rapporto P/E:
-0.00188
EPS:
-3530.8178
Flusso di cassa netto:
$-36.78M
1 W Prestazione:
+17.14%
1M Prestazione:
+33.94%
6M Prestazione:
-12.07%
1 anno Prestazione:
-43.43%
Intervallo 1D:
$6.50
$6.7427
Intervallo di 1 settimana:
$5.50
$7.15
Portata 52W:
$3.39
$16.00
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Nome
Avalo Therapeutics Inc
Settore
Industria
Telefono
410-522-8707
Indirizzo
1500 LIBERTY RIDGE DRIVE, WAYNE
Confronta AVTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
6.63 | 69.51M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-25 | Iniziato | Jefferies | Buy |
| 2025-03-25 | Iniziato | Stifel | Buy |
| 2025-02-28 | Iniziato | Piper Sandler | Overweight |
| 2025-02-21 | Iniziato | Wedbush | Outperform |
| 2024-12-19 | Iniziato | BTIG Research | Buy |
| 2024-10-24 | Iniziato | H.C. Wainwright | Neutral |
| 2024-04-16 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-09-24 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Avalo Therapeutics Inc Borsa (AVTX) Ultime notizie
What drives Avalo Therapeutics Inc. stock priceOverwhelming financial success - PrintWeekIndia
When is the best time to buy Avalo Therapeutics Inc. stockExceptional trading performance - jammulinksnews.com
What analysts say about Avalo Therapeutics Inc. stockUnmatched market gains - Autocar Professional
Avalo Therapeutics Inc. Stock Analysis and ForecastBreakthrough stock performance - jammulinksnews.com
Is Avalo Therapeutics Inc. a good long term investmentUnmatched market performance - jammulinksnews.com
Stifel reiterates Buy rating on Avalo Therapeutics stock, maintains $36 target By Investing.com - Investing.com South Africa
Stifel reiterates Buy rating on Avalo Therapeutics stock, maintains $36 target - Investing.com Australia
Avalo Therapeutics Soars 10.66% on Bullish Sentiment - AInvest
Avalo Therapeutics (AVTX) Soars 10.42% on Analyst Upgrade - AInvest
What makes Avalo Therapeutics Inc. stock attractive to long term investorsBalanced Risk Reward Portfolio - Newser
Does Avalo Therapeutics Inc. stock pay reliable dividendsReal Time Alert Service - Newser
What institutions are buying Avalo Therapeutics Inc. stock nowGrowth Optimized Stock Radar - beatles.ru
What makes Avalo Therapeutics Inc. stock price move sharplyBreakout Confirmation Tool - Newser
Why Avalo Therapeutics Inc. stock attracts strong analyst attentionIntraday Trade Ideas - Newser
How Avalo Therapeutics Inc. stock performs during market volatilityVolume Spike Monitors - Newser
(AVTX) Investment Analysis and Advice - news.stocktradersdaily.com
Avalo Adds Dr. Rita Jain to Board as LOTUS Trial Advances - MSN
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
How To Trade (AVTX) - news.stocktradersdaily.com
15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey
Avalo Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire
Avalo Therapeutics Highlights Potential of AVTX-009 in HS - TipRanks
(AVTX) Long Term Investment Analysis - news.stocktradersdaily.com
Avalo Therapeutics appoints Dr. Rita Jain to board of directors By Investing.com - Investing.com Nigeria
Avalo Therapeutics (AVTX) Welcomes New Board Member | AVTX Stock News - GuruFocus
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors - GlobeNewswire
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to B - GuruFocus
Avalo Therapeutics appoints Dr. Rita Jain to board of directors - Investing.com
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Down 45.8% in May - Defense World
AVTX Virtual Meeting Scheduled for June 23 by BTIG | AVTX Stock News - GuruFocus
Brokerages Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) PT at $30.00 - Defense World
Avalo Therapeutics Signs New Sales Agreement - TipRanks
Avalo Therapeutics Inc Azioni (AVTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):